1. Generics Bulletin

Hikma Opens Discussions To Acquire GSK Businesses In Egypt And Tunisia

Deal Would Include Hikma Acquiring GSK’s 91.2% Holding

 
• By Dean Rudge

With operations in the MENA region already tracking to $700m in revenues for 2020, Hikma is looking to grow the business further after beginning negotiations with GSK to buy certain of the originator’s businesses in Egypt and Tunisia.

Earth
Hikma already has a significant presence in the MENA region, striking several licensing deals in 2020. • Source: Shutterstock

Hikma has approached GlaxoSmithKline to potentially acquire certain GSK businesses in Egypt and Tunisia.

The London-based generics and injectables player has entered a non-binding term sheet for the Pharmaceutical and Consumer Health business in Egypt, including manufacturing, and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business